According to recent findings from the IMARC Group, the total size of the healthcare cold chain logistic services market is forecasted to expand to nearly US$13.4 billion in the next five years.
In response to the market’s forecasted growth, global logistics firm DHL hailed the need to invest in a new generation of smarter cold chains. The firm noted: "With global demand, particularly in emerging markets, growing hand in hand with
ever stricter compliance from regulators, the industry faces a critical situation unless a new generation of cold chains are developed that can support growth aspirations and at the same time safeguard products."
Another incentive to invest is presented by the diversification in drug demand. DHL added: "Specialty drugs and biologics are one of the fastest growth areas with US
spending on specialty drugs to quadruple to US$401.7 billion in 5 years, according
to PricewaterhouseCoopers, with similar growth rates being projected for the rest
of the world.
In this report, Cold Chain IQ presents its research into Temperature Controlled
Logistics investment levels for 2015.
| Have Your Say Rate this feature and give us your feedback in the comments section below |